Skip to content

Prospective, Single-Center, Single-Arm Clinical Trial on the Safety and Efficacy of Single-Port Single-Arm Robotic Surgery in the Resection of Benign Parotid Tumors

Prospective, Single-Center, Single-Arm Clinical Trial on the Safety and Efficacy of Single-Port Single-Arm Robotic Surgery in the Resection of Benign Parotid Tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100625
Enrollment
Unknown
Registered
2025-04-11
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Parotid Tumor

Interventions

Intervention Group:Parotid tumor resection using the Single-Port Single-Arm Robotic Surgical System

Sponsors

Zhujiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1?Diagnostic Criteria: Meeting the diagnostic criteria for benign parotid tumors as outlined in the 4th edition (2017) of the WHO Classification of Head and Neck Tumors. 2?Adults aged 18 years or older,regardless of gender; 3?Adequate physical condition to undergo laparoscopic surgery; 4?Willing to cooperate and complete follow-up visits and related examinations as required by the trial; 5?Signed informed consent form, voluntarily agreeing to participate in this trial.

Exclusion criteria

Exclusion criteria: 1?Presence of heart, liver, lung, kidney, or other diseases that render the patient unable to tolerate surgery; 2?Women who are pregnant or lactaing; 3?History of epilepsy or psychiatric disorders that are not effectively controlled; 4?Severe allergic constitution, or suspected or confirmed alcohol or drug addiction; 5?Severe systemic infectious diseases; 6?Patients who are unble to understand the study requirements or complete the follow-up plan; 7?Malignant tumors with unclear boundaries from surrounding tissues; 8?Other conditions deemed by the investigator as unsuitable for participation in this trial(such as unwillingness to comply with the study plan, unrealistic expectations, or significant emotional issues);

Design outcomes

Primary

MeasureTime frame
Intraoperative blood loss;

Countries

China

Contacts

Public ContactLv Xiaozhi

Zhujiang Hospital of Southern Medical University

lxzsurgeon@126.com+86 20 6278 2092

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026